Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Aug;7(4):160-8.
doi: 10.1177/1759720X15582144.

Oral bisphosphonates and colon cancer: an update

Affiliations
Review

Oral bisphosphonates and colon cancer: an update

Pia Eiken et al. Ther Adv Musculoskelet Dis. 2015 Aug.

Abstract

Bisphosphonates (BPs) are widely used as the main treatment for osteoporosis. In vitro and animal studies suggest that use of BPs may have a potential for colorectal cancer (CRC) prevention. Safety and efficacy in terms of osteoporosis prevention have only been evaluated in randomized controlled trials (RCTs) of relatively short duration (3-5 years), with smaller extension studies. The evidence for a benefit beyond 5 years is limited and intake of BPs has not shown any relationship with CRC in intervention studies. Observational studies and meta-analysis have shown unchanged or decreased risk of CRC. BPs used for treatment and prevention of osteoporosis should not be applied for prevention of CRC in clinical practice.

Keywords: bisphosphonates; colorectal cancer; risk.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: P.E. is an advisory board member with Eli Lilly, Amgen and MSD, and on the speakers bureau with Amgen and Eli Lilly. P.V. has received unrestricted grants from MSD and Servier, and travel grants from Amgen, Eli Lilly, Novartis, Sanofi-Aventis and Servier.

References

    1. Ballester I., Daddaoua A., Lopez-Posadas R., Nieto A., Suarez M., Zarzuelo A., et al. (2007) The bisphosphonate alendronate improves the damage associated with trinitrobenzenesulfonic acid-induced colitis in rats, Br J Pharmacol 151: 206–215. - PMC - PubMed
    1. Black D., Reid I., Boonen S., Bucci-Rechtweg C., Cauley J., Cosman F., et al. (2012) The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT), J Bone Miner Res 27: 243–254. - PMC - PubMed
    1. Black D., Schwartz A., Ensrud K., Cauley J., Levis S., Quandt S., et al. (2006) Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial, JAMA, 296: 2927–2938. - PubMed
    1. Böhning D. (2000) Computer-assisted Analysis of Mixtures and Applications: Meta-analysis, Disease Mapping and Others. Boca Raton, FL: Chapman & Hall/CRC Press.
    1. Bone H., Hosking D., Devogelaer J., Tucci J., Emkey R., Tonino R., et al. (2004) Ten years’ experience with alendronate for osteoporosis in postmenopausal women, New Engl J Med 350: 1189–1199. - PubMed

LinkOut - more resources